SPL 1.06% 9.5¢ starpharma holdings limited

SPL7013 outperformed Gilead against COVID-19, page-4

  1. 587 Posts.
    lightbulb Created with Sketch. 79
    Honestly, I cannot see how this is good news for SPL. good news for the world, but not SPL. If remdesivir works it reduces the need for SPL7013. the potential application is also different, so a comparison is hard to make. It’s especially hard to claim / imply SPL7013 is a superior option...

    We may get a bounce along with the market, but my view is that you buy SPL for their DEP Technology. Buying for potential COVID applications is pure speculation / gamble IMO.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.001(1.06%)
Mkt cap ! $38.76M
Open High Low Value Volume
9.6¢ 9.7¢ 9.5¢ $1.207K 12.48K

Buyers (Bids)

No. Vol. Price($)
2 7755 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 13402 4
View Market Depth
Last trade - 11.06am 04/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.